Literature DB >> 3196889

Comment on 'Difference between R5020 and the anti progestin RU486 in antiproliferative effects on human breast cancer cells'.

M R Moore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196889     DOI: 10.1007/bf01805744

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  5 in total

1.  Effects of progestins on growth of experimental breast cancer in culture: interaction with estradiol and prolactin and involvement of the polyamine pathway.

Authors:  A Manni; B Badger; C Wright; S R Ahmed; L M Demers
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

2.  Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth.

Authors:  S M Longman; G C Buehring
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

3.  Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model.

Authors:  S P Robinson; V C Jordan
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

4.  Progestin effects on growth in the human breast cancer cell line T-47D--possible therapeutic implications.

Authors:  J R Hissom; M R Moore
Journal:  Biochem Biophys Res Commun       Date:  1987-06-15       Impact factor: 3.575

5.  Actions of a progestogen on human breast cancer cells: mechanisms of growth stimulation and inhibition.

Authors:  H Braunsberg; N G Coldham; R E Leake; S K Cowan; W Wong
Journal:  Eur J Cancer Clin Oncol       Date:  1987-05
  5 in total
  1 in total

1.  Evaluation of a recombinant yeast cell estrogen screening assay.

Authors:  N G Coldham; M Dave; S Sivapathasundaram; D P McDonnell; C Connor; M J Sauer
Journal:  Environ Health Perspect       Date:  1997-07       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.